Founded in 1901, Children’s Hospital Los Angeles (CHLA) is a pediatric academic medical center built around its mission of creating hope and building healthier futures. Renowned for its world-class clinical care, leading-edge research, and one of the most successful pediatric training programs in the country, CHLA performs more than 17,000 surgeries and sees more than 600,000 patient visits annually. Last year, CHLA treated over 132,000 individuals.
Providing $316.2 million in community benefits, CHLA at its core reflects its physicians, nurses, and clinical staff, who provide compassionate and lifesaving care for young patients from around the world. In the U.S. New & World Report’s “Honor Roll of Best Children’s Hospitals,” CHLA ranked No. 1 in the Western United States and No. 5 nationally for the second straight year. CHLA also had seven sub-specialties in the top 10 nationwide.
CHLA’s Cancer and Blood Disease Institute (CBDI) has been saving lives and working to improve cure rates through exceptional care, innovative research, and academic excellence for nearly six decades. The CBDI provides care for more than 2,000 new patients each year and completes approximately 36,500 outpatient visits annually. In 2019, the U.S. News & World Report ranked the CBDI as the top pediatric hematology/oncology program in California and No. 10 in the nation. The Institute has been continuously ranked in the top ten every year since these rankings were launched.